POLISH FINANCIAL SUPERVISION AUTHORITY

Current Report No 94/2016

Made on 2016-09-29

The issuer's name Magellan S.A.

Subject Entering into an important agreement

Legal grounds Art. 17 title 1 of MAR - confidential information

Report content:

Magellan S.A. Management Board hereby informs that on 29 September 2016 the Company's subsidiary - MEDFinance S.A. entered into an important agreement with Polish leading financial institution for the total nominal value of PLN 75,000 thousand.

This is the loan agreement with three limits for the amount of PLN 25,000 thousand each and four-year maturity from the dates of payments (maximum 31 March 2017). The interest rate of the loan was calculated based on 6M WIBOR + the margin. The loan is aimed at financing of the current operations of MEDFinance S.A. and its specific terms and conditions are not different from the market standards used in this type of contracts. Magellan S.A. issued the corporate guarantee to secure the loan granted to the subsidiary.

The financing limits granted to MEDFinance S.A. by Polish leading financial institution are for the total nominal value PLN 250,000 thousand as at the date of the report.

Vice-President, Management Board Member, Management Board

Grzegorz Grabowicz Rafał Karnowski

Magellan SA published this content on 29 September 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 05 October 2016 13:49:04 UTC.

Original documenthttp://www.magellansa.pl/Portals/1/Files/Raporty/Raporty biezace/EN/2016/094_Umowa_pozyczki_ENG.pdf

Public permalinkhttp://www.publicnow.com/view/85ECE5416DC03E4774010D60C1B75FF09DF0D0AF